Efficacy of Terbinafine 1% Cream on Seborrhoeic Dermatitis

Seborrhoeic dermatitis (SD) is a common chronic inflammatory skin disease. Although the exact pathogenesis of SD is unknown, Malassezia yeasts as well as genetic and environmental factors have been implicated. The aim of this study was to evaluate the efficacy of terbinafine 1% cream on SD lesions with face localisation. Thirty‐five patients with SD were included in the study. Patients applied terbinafine 1% cream twice daily for four weeks. The severity of the signs (erythema, scaling, infiltration) was assessed using a 4‐point score (0=absent, 1=mild, 2=moderate, and 3=intense) at baseline and at the 2nd and 4th weeks of the therapy. Also, self‐assessment was done by the patients on a 100 mm visual analogue score (VAS) at each visit. Complete remission was observed in 10 (32.3%) patients at the end of the therapy. Statistically significant reductions in the scores of all parameters were observed at both the 2nd and 4th weeks of the therapy. Patients' self assessments in the 2nd and 4th weeks were similarly better than at the baseline.

[1]  H. Serhat.  The Pathogenesis and Treatment of Seborrhoeic Dermatitis , 2004 .

[2]  L. Misery,et al.  [Treatment for seborrheic dermatitis]. , 2004, Annales de dermatologie et de venereologie.

[3]  O. Chosidow,et al.  Randomized, Open-Labeled, Non-Inferiority Study between Ciclopiroxolamine 1% Cream and Ketoconazole 2% Foaming Gel in Mild to Moderate Facial Seborrheic Dermatitis , 2003, Dermatology.

[4]  G. Vena,et al.  Oral terbinafine for the treatment of seborrheic dermatitis in adults , 2002, International journal of dermatology.

[5]  Shinichi Watanabe,et al.  Ketoconazole suppresses interleukin-4 plus anti-CD40-induced IgE class switching in surface IgE negative B cells from patients with atopic dermatitis. , 2002, The Journal of investigative dermatology.

[6]  G. Piérard,et al.  A Double-Blind Placebo-Controlled Study of Ketoconazole + Desonide Gel Combination in the Treatment of Facial Seborrheic Dermatitis , 2002, Dermatology.

[7]  K. Goode,et al.  A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral ® ) for the treatment of dandruff/seborrhoeic dermatitis , 2002, The Journal of dermatological treatment.

[8]  S. Watanabe,et al.  Anti-mycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis. , 2001, The Journal of investigative dermatology.

[9]  J. Faergemann.  Treatment of seborrhoeic dermatitis with oral terbinafine? , 2001, The Lancet.

[10]  J. Arrese,et al.  Effect of Ketoconazole 1% and 2% Shampoos on Severe Dandruff and Seborrhoeic Dermatitis: Clinical, Squamometric and Mycological Assessments , 2001, Dermatology.

[11]  G. Quadri,et al.  Evaluation of the efficacy and tolerability of oral terbinafine (Daskil®) in patients with seborrhoeic dermatitis. A multicentre, randomized, investigator‐blinded, placebo‐controlled trial , 2001, The British journal of dermatology.

[12]  J. Faergemann.  Management of Seborrheic Dermatitis and Pityriasis Versicolor , 2000, American journal of clinical dermatology.

[13]  Parry,et al.  Seborrhoeic dermatitis is not caused by an altered immune response to Malassezia yeast , 1998, The British journal of dermatology.

[14]  J. Burton,et al.  Susceptibility of Malassezia furfur subgroups to terbinafine , 1997, The British journal of dermatology.

[15]  Y. Loria,et al.  Pityrosporum ovale (Malassezia furfur) as the causative agent of seborrhoeic dermatitis: new treatment options , 1996, The British journal of dermatology.

[16]  D. Barker,et al.  Correlation of Pityosporum ovale density with clinical severity of seborrheic dermatitis as assessed by a simplified technique. , 1990, Journal of the American Academy of Dermatology.

[17]  G. Petrányi,et al.  Antifungal activity of the allylamine derivative terbinafine in vitro , 1987, Antimicrobial Agents and Chemotherapy.

[18]  S. Shuster,et al.  Treatment of seborrhoeic dermatitis with ketoconazole: II. Response of seborrhoeic dermatitis of the face, scalp and trunk to topical ketoconazole , 1987, The British journal of dermatology.

[19]  P. Farr,et al.  The response of seborrhoeic dermatitis to ketoconazole , 1984, The British journal of dermatology.